HealthTree Foundation at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
HealthTree Foundation exhibits at Booth 2924 at ASH 2026 in New Orleans. Its presence centres on blood cancer treatment choices, supporting symposia on CAR T standards in lymphoma, fixed-duration BTK inhibitor treatment in CLL and next steps after myeloma relapse.
| Organization | ASH 2026 Attendance |
|---|---|
HealthTree Foundation South Jordan, UT | |
Patient nonprofit whose free health record app gathers blood cancer patients' data to match them with trials, education and support, and power research. | Booth Exhibiting at Booth 2924 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00pm–10:00pm Accelerating CARs for Lymphoma: Expert Workshops on CAR-T Standards, Sequencing, and Emerging Cellular Therapy Platforms CAR-T as standard lymphoma care and what comes next, including dual-target, faster-manufactured, and in vivo versions that could widen patient access. Symposium Fri Dec 11 3:00pm–6:00pm FAST Track to Enhanced CLL Outcomes: Finite Therapy Advances With BTK Inhibitors as New STandards for Frontline Treatment Time-limited frontline chronic lymphocytic leukemia treatment pairing Bruton tyrosine kinase and Bcl-2 inhibitors, tailored to patient goals and risk. Symposium Fri Dec 11 7:00am–10:00am Next in Line for Relapsed/Refractory Myeloma: Sequencing Strategies With T-Cell Engagers, Next-Generation CAR-T, and Innovative MOAs Sequencing relapsed myeloma treatments as next-generation CAR-T, multi-target T-cell engagers, and new drug classes arrive, plus managing their toxicity. |
Instantly find 20 buyers from HealthTree Foundation
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction